What's New: Newly Approved Drugs for Children

    July 2003 in “ Pediatrics in review ”
    Myles B. Abbott, Robert H. Levin
    Image of study
    TLDR In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.
    In 2001, the FDA approved 66 new drugs, including 12 with pediatric indications that are clinically important for general pediatricians. These drugs include treatments for allergy and asthma, ADHD, birth control, and other conditions. Clarinex® is an antihistamine for allergic rhinitis and urticaria in children over 12. Foradil® Aerolizer is a long-acting beta2-agonist for asthma maintenance and prevention in children over 5 and for exercise-induced bronchospasm in those over 12. Ventolin® HFA is a short-acting beta2-agonist for acute asthma management in children over 4. Adderall XR®, Focalin®, and Metadate CD® are central nervous system stimulants for ADHD in children over 6. NuvaRing®, Ortho Evra®, and Yasmin® are contraceptives with various delivery methods. Augmentin ES-600® is an oral antibiotic for otitis media in children under 40 kg. Elidel® is an immunomodulator for atopic dermatitis in patients over 2 who don't respond to conventional therapies. Tazorac® is a topical retinoid for acne vulgaris in children over 12. The document acknowledges Express Scripts for providing drug monographs.
    Discuss this study in the Community →

    Related Community Posts Join

    2 / 2 results

    Similar Research

    5 / 20 results
      Acne and Its Management

      research Acne and Its Management

      7 citations, November 2013 in “Pediatrics in Review”
      Acne is a chronic skin condition not caused by poor hygiene or diet, and it requires long-term treatment and patient education.
      Side Effects of Common Acne Treatments

      research Side Effects of Common Acne Treatments

      38 citations, November 2012 in “Expert Opinion on Drug Safety”
      Common acne treatments can cause various side effects, like skin irritation and more serious issues, but combination therapies are often more effective and better tolerated.
      Common Dermatologic Conditions

      research Common Dermatologic Conditions

      14 citations, April 2014 in “Medical Clinics of North America”
      The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.
      Acne

      research Acne

      58 citations, January 1997 in “Dermatologic Clinics”
      Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.